Bio Green Med Solution, Inc. — Director's Dealing 2013

Dec 10, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2013-12-09

Reporting Person: McBarron Paul (Director, E.V.P.,Finance,C.F.O. & C.O.O.)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-09	Option	$4.61	A	70000	Acquired	2023-12-09	Common Stock (70000)	Direct

Footnotes

F1: These options are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.

F2: These securities were issued as part of the Issuer's annual equity compensation to executive officers.